27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
It's a great time to invest in pharmaceutical companies such as AbbVie Inc (NYSE:ABBV), Cerity Partners' Jim Lebenthal shared Wednesday on CNBC's "Fast Money Halftime Report."
Lebenthal told CNBC that he is slowly building the pharmaceutical portion of his portfolio. AbbVie is a great franchise currently trading at a good valuation, Lebenthal said.
Recently, he added Bristol-Myers Squibb Company (NYSE:BMY) to his portfolio.
AbbVie announced today it will report its second-quarter financial results on July 30 before the market opens.
ABBV Price Action: AbbVie has traded as high as $118.28 and as low as $79.11 over a 52-week period.
At last check Wednesday, the stock was up 0.57% at $116.46.
Photo: Courtesy of AbbVie.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!